Sign up
Log in
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 98.3% to $4.62 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.4 million.
  • GlycoMimetics (NASDAQ:GLYC) stock moved upwards by 25.91% to $0.29. The market value of their outstanding shares is at $18.3 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock rose 24.78% to $3.85. The company's market cap stands at $2.0 million.
  • Forte Biosciences (NASDAQ:FBRX) shares rose 22.62% to $8.4. The market value of their outstanding shares is at $53.7 million.
  • Rezolute (NASDAQ:RZLT) stock rose 21.28% to $3.77. The company's market cap stands at $228.3 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares increased by 17.11% to $2.19. The company's market cap stands at $3.0 million.

Losers

  • Serina Therapeutics (AMEX:SER) stock fell 21.6% to $4.31 during Wednesday's pre-market session. The company's market cap stands at $42.8 million.
  • Gelteq (NASDAQ:GELS) stock declined by 17.37% to $2.38. The market value of their outstanding shares is at $22.4 million.
  • NeOnc Technologies (NASDAQ:NTHI) shares decreased by 16.39% to $5.0. The market value of their outstanding shares is at $112.8 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 15.26% to $5.11. The company's market cap stands at $43.7 million.
  • Intensity Therapeutics (NASDAQ:INTS) stock decreased by 13.62% to $1.65. The market value of their outstanding shares is at $25.0 million.
  • Petros Pharma (NASDAQ:PTPI) shares declined by 12.46% to $0.05. The market value of their outstanding shares is at $1.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.